EXAS Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: February 17, 2026
Report Source: 2025 Annual Report
Exact Sciences Corp. Stock Analysis EXAS
EXACT Sciences Corp. is a cancer screening and diagnostics company. The company is headquartered in Madison, Wisconsin and currently employs 7,100 full-time employees. The company went IPO on 2001-01-30. The firm provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
Read More Exact Sciences Corp (EXAS) Chart
Key Statistics of Exact Sciences Corp (EXAS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$104.93Volume
21.56MP/E Ratio (TTM)
-52 Week Range
Market Cap
19.72BAvg. Volume
8.32MDividend Yield
-Financial Metrics & Statements of Exact Sciences Corp (EXAS)
Community-Curated Collections with Exact Sciences Corp (EXAS) ( With EXAS )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's for Exact Sciences Corp (EXAS)
- According to Musaffa’s Shariah screening methodology, Exact Sciences Corp (EXAS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.